February 6, 2017
Kiadis Pharma in phase 3 with leukemia drug ATIR101
Kiadis Pharma has started its phase III trial with its major products for blood cancer hematopoietic stem cell transplantation (HSCT) ATIR101.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: ATIR201